Article content
NEW YORK — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will participate in the following investor conferences:
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
- Stifel 2025 Healthcare Conference
- Format: Presentation
- Date and Time: Wednesday, November 12, 2025 at 1:20 PM ET
- Location: New York, NY
- Webcast Link: Stifel 2025 Healthcare Conference
- Jefferies Global Healthcare Conference in London
- Format: Presentation
- Date and Time: Tuesday, November 18, 2025 at 12:00 PM GMT
- Location: London, UK
- Webcast Link: Jefferies Global Healthcare Conference in London
- 8th Annual Evercore Healthcare Conference
- Format: Fireside Chat
- Date and Time: Tuesday, December 2, 2025 at 12:30 PM ET
- Location: Coral Gables, FL
- Webcast Link: 8th Annual Evercore Healthcare Conference
- Piper Sandler 37th Annual Healthcare Conference
- Format: Fireside Chat
- Date and Time: Wednesday, December 3, 2025 at 3:00 PM ET
- Location: New York, NY
- Webcast Link: Piper Sandler 37th Annual Healthcare Conference
Article content
Article content
Article content
Audio webcasts and replays of available presentations will be accessible on MindMed’s Investor Relations website for up to 90 days following each event.
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
About MindMed
Article content
MindMed is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates targeting neurotransmitter pathways that play key roles in brain health.
Article content
MindMed trades on NASDAQ under the symbol MNMD.
Article content
Article content
Article content
Article content
View source version on businesswire.com:
Article content
Article content

Article content
Contacts
Article content
Investors:
Article content
Article content
Gitanjali Jain
Article content
Article content
VP, Head of Investor Relations
Article content
Article content
Article content
Media:
Article content
Article content
Article content
Article content

2 hours ago
2
English (US)